Navigation Links
OriGene named to Deloitte’s 2013 North America Technology Fast 500
Date:11/21/2013

Rockville, Maryland (PRWEB) November 21, 2013

OriGene, a privately held biotech company, was selected as one of fastest growing technology companies in North America. On Nov 13th, Deloitte released the 2013 Technology Fast 500™, an annual ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Award winners were selected based on percentage fiscal year revenue growth from 2008 to 2012. For more information on fast500, visit http://www.fast500.com.

About OriGene
OriGene Technologies, Inc. develops, manufactures, and sells genome wide research and diagnostic products worldwide. As the leading gene tool company and is establishing its unique position as the provider of the most specific anitbodies.

For more information, visit http://www.origene.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11349233.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Latest Cell Publication of OriGene and Peking University Collaborative Discovery of New iPSC Reprogramming Factors
2. OriGene to Acquire SDIXs Life Science Business Assets
3. OriGene Technologies Raises $21.3 Million in Series C Funding
4. The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program
5. Three World-Renowned Philadelphia Scientists Are Named As Recipients Of The 2013 John Scott Award
6. Synthetic Biologics SYN-004 for the Prevention of C. difficile Infections Named a "Top Project to Watch" by Elsevier Business Intelligence
7. DuPont Named Top Employer by Science Magazine for the 6th Consecutive Year
8. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
9. Moderna Therapeutics Named to the World Economic Forums Community of "Global Growth Companies"
10. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
11. Scioderm, Inc. Named a 2013 "Fierce Top 15" Company by FierceBiotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... Non-profit Consortium Aims to Generate Genomic ... Research and Discovery --> --> ... plan to sequence 100,000 individuals. It is intended to initially ... 7 of North and East Asian countries. ... project will focus on creating phased reference genomes for all ...
(Date:2/11/2016)... Texas , Feb. 11, 2016  Vermillion, Inc. ... on gynecologic disease, today announced the formation of the ... --> --> Pelvic masses ... both diagnosis and management. Once pregnancy is ruled out, ... tubes and ovaries, advanced endometriosis, benign ovarian tumors and ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
Breaking Biology Technology:
(Date:2/9/2016)... 9, 2016 Vigilant Solutions announces today that an ... to develop a lead in a difficult homicide case. The ... to locate the suspect vehicle. Due to the ongoing investigation, ... been omitted at the agency,s request. --> ... "Our victim was found deceased at an intersection here in ...
(Date:2/3/2016)... 2016 --> ... "Automated Fingerprint Identification System Market by Component (Hardware and ... & Finance, Government, Healthcare, and Transportation) and Geography - ... is expected to be worth USD 8.49 Billion by ... and 2020. The transformation and technology evolution from the ...
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
Breaking Biology News(10 mins):